Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Altern Complement Med ; 14(9): 1097-105, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19055335

ABSTRACT

OBJECTIVE: Many claims have been made regarding the therapeutic efficacy of acupuncture. However, most controlled clinical studies have been limited to treatment of pain-related disorders and do not provide objective, quantifiable data for analysis. Traditional acupuncture has been applied to chronic obstructive pulmonary disease (COPD). However, only a few studies have been performed to determine the efficacy of this treatment. This study was conducted to determine whether a combination of traditional acupuncture treatment and conservative treatment for COPD improves dyspnea on exercise. METHODS: This was a prospective trial with matched-pair parallel groups of patients from the departments of respiratory internal medicine of Gifu University of Medicine, Meiji University of Oriental Medicine, and Gifu Red Cross Hospital, Japan. Thirty patients were divided into the acupuncture group (n = 15) and the control group (n = 15). The control group received conservative treatment with medication only. The acupuncture group received acupuncture treatments once a week for 10 weeks, in addition to conservative treatment with medication. The main outcome measure was the Modified Borg dyspnea scale after the 6-minute walk test. RESULTS: The acupuncture group had significantly better results on the Borg scale than the control group after 10 weeks (2.2 +/- 2.7 versus 6.4 +/- 3.4, p = 0.0001, 95% confidence interval, -5.10 to -2.35, paired t-test). The 6-minute walk distance and oxygen saturation at the minimum rate improved significantly in the acupuncture group compared with the control group. CONCLUSIONS: This study demonstrated that acupuncture contributed to the reduction of COPD-related dyspnea on exercise in 15 matched-pair parallel subjects.


Subject(s)
Acupuncture Points , Acupuncture Therapy/methods , Dyspnea/therapy , Patient Satisfaction/statistics & numerical data , Pulmonary Disease, Chronic Obstructive/therapy , Adult , Confidence Intervals , Dyspnea/etiology , Female , Humans , Japan , Male , Middle Aged , Odds Ratio , Prospective Studies , Pulmonary Disease, Chronic Obstructive/complications , Treatment Outcome
2.
Life Sci ; 77(12): 1391-403, 2005 Aug 05.
Article in English | MEDLINE | ID: mdl-15925389

ABSTRACT

We examined a possible preventive effect of Linderae radix (LR), the root of Lindera strychnifolia, on the progression of diabetic nephropathy. Water extract of Linderae radix (LR extract) was orally administered to the C57BL/KsJ-db/db (db/db) mice, a model of genetic diabetes, at a dose of 730 mg/kg/day for 12 week. The LR extract treatment did not affect glucose metabolism and systolic pressure. However, it resulted in a better renal function as evaluated by creatinine clearance (Ccr) and serum creatinine than the control; Ccr and serum creatinine were progressively worsened in controls (0.13+/-0.01 (l/day) and 0.69+/-0.04 (mg/dl), respectively) whereas unchanged in the treated group (0.24+/-0.03 (l/day), p<0.05 and 0.53+/-0.04 (mg/dl), p<0.05, respectively). Kidneys of the LR extract-treated group showed glomeruli with greater area and cell population, smaller glomerular sclerotic index, and less fibrosis in glomeruli, where apoptotic rate of glomerular cells were decreased compared with the control kidneys. Furthermore, renal TGF-beta(1) expression was decreased in the LR extract-treated group. These findings suggest that the LR therapy can be a novel therapeutic approach against diabetic nephropathy.


Subject(s)
Diabetic Nephropathies/drug therapy , Lindera/chemistry , Phytotherapy , Animals , Apoptosis/drug effects , Blood Chemical Analysis , Blood Glucose/metabolism , Body Weight/drug effects , Diabetic Nephropathies/pathology , Disease Progression , Eating/drug effects , Glycated Hemoglobin/metabolism , Immunohistochemistry , In Situ Nick-End Labeling , Kidney/pathology , Mice , Mice, Inbred C57BL , Microscopy, Electron , Plant Extracts/therapeutic use , Plant Roots/chemistry , Transforming Growth Factor beta/biosynthesis
3.
Nihon Kokyuki Gakkai Zasshi ; 43(5): 289-95, 2005 May.
Article in Japanese | MEDLINE | ID: mdl-15969210

ABSTRACT

Chronic obstructive pulmonary disease (COPD) involves a decrease in respiratory function and limits daily activities. We report a COPD patient whose respiratory symptoms were improved by acupuncture treatment. A 66-year-old man visited Gifu University Hospital with breathlessness on exercise. Despite medication, his general condition worsened. A series of acupuncture treatments was subsequently started on October 27, 2001. He had level III breathlessness on JRS classification prior to acupuncture treatment, and his respiratory function parameters were VC: 3.54 L, FEV1: 1.19 L, FEV1% (G): 33.6% and %FEV1: 45%. The basic meridian points used were KI 3 (Fuliu), LU 9 (Taiyuan), LU 1 (Zhongfu), CV 12 (Zhongwan), CV 4 (Guanyuan), BL 13 (Feishu), and BL 23 (Shenshu). The acupuncture needles were retained for ten minutes in each session. This research design was used to detect the specific efficacy of acupuncture treatment After ten acupuncture treatments over two months, his walking distance, Borg scale and respiratory function were improved compared with before treatment. These findings suggest that acupuncture treatment may be efficacious for advanced cases of COPD.


Subject(s)
Acupuncture Therapy , Pulmonary Disease, Chronic Obstructive/therapy , Respiration , Acupuncture Points , Aged , Humans , Male , Meridians , Pulmonary Disease, Chronic Obstructive/physiopathology
4.
Am J Chin Med ; 32(4): 587-98, 2004.
Article in English | MEDLINE | ID: mdl-15481648

ABSTRACT

Lindera strychnifolia (tendai-uyaku), a medicinal plant, has long been used for the treatment of cardiac, renal and rheumatic diseases in Japan. We aim to clarify (1) whether L. strychnifolia is protective against post-ischemic myocardial dysfunction, and (2) whether its effect is related to scavenging hydroxyl radicals and opening the mitochondrial KATP channels in isolated rat hearts. Male Sprague-Dawley rats were orally given 1 ml/day of L. strychnifolia, which was extracted from 0.75 and 1.5 g/kg of roots of L. strychnifolia for 4 days. The rat hearts were excised and perfused on a Langendorff apparatus with Krebs-Henseleit solution with a gas mixture of 95% O2 and 5% CO2. The hearts were paced at 320 beats/min except during ischemia. Left ventricular developed pressure (LVDP, mmHg), +/- dP/dt (mmHg/sec) and coronary flow (ml/min) were continuously monitored. All hearts were perfused for a total of 120 minutes consisting of a 30-minute pre-ischemic period followed by 30 minutes of global ischemia and 60 minutes of reperfusion with or without 5-HD, a mitochondrial KATP channel blocker. The levels of lactate, LDH and 2,5-DHBA, an indicator of hydroxyl radicals, in the perfusate during reperfusion period were also measured. Treatment with L. strychnifolia significantly improved LVDP and +/- dP/dt without altering coronary flow during reperfusion. The 100 microM of 5-HD in Krebs-Henseleit solution was perfused during the 10 minutes of pre-ischemic periods. Pretreatment with 5-HD abolished the improvement of LVDP and +/- dP/dt by L. strychnifolia. L. strychnifolia significantly attenuated the levels of lactate, LDH and 2,5-DHBA during reperfusion, and which were restored by pretreatment with 5-HD. In conclusion, L. strychnifolia is protective against post-ischemic left ventricular dysfunction through scavenging hydroxyl radicals and opening the KATP channels in the isolated rat heart.


Subject(s)
Heart/drug effects , Hydroxyl Radical/metabolism , Lindera , Membrane Proteins/physiology , Myocardial Ischemia/prevention & control , Plant Preparations/pharmacology , Animals , Chromatography, High Pressure Liquid/methods , Gentisates/metabolism , Heart/physiopathology , In Vitro Techniques , L-Lactate Dehydrogenase/metabolism , Male , Myocardial Ischemia/metabolism , Myocardial Ischemia/physiopathology , Plant Preparations/therapeutic use , Potassium Channels , Rats , Rats, Sprague-Dawley , Ventricular Function, Left/drug effects
5.
Am J Chin Med ; 31(6): 857-69, 2003.
Article in English | MEDLINE | ID: mdl-14992538

ABSTRACT

Lindera strychifolia, a scandent shrub Lauraceous medicinal plant, has been used in Chinese traditional medicine as a palliative and an anti-spasmodic. It also shows cytotoxic effects against several tumor cell lines and inhibits marcromolecule biosynthesis. This study investigated the anti-tumor effects of L. strychifolia extract against lung cancer cells using in vitro and in vivo models. Two human lung cancer cell lines A549 (adenocarcinoma) and SBC-3 (small cell carcinoma), and a non-tumor cell line 3T3-L1 (mice fibroblasts) were subjected to L. strychifolia extract treatment. On lung cancer cells, L. strychifolia induced cell growth inhibition in a dose-dependent manner. Conversely, the extract did not show any significant cytotoxic effect on 3T3-L1 cells. Therefore, the extract is specific for tumor cells. Tumor cells treated with L. strychifolia extract showed typical morphological appearance of apoptosis including nuclei fragmentation and cell condensation. The in vivo effects of L. strychifolia extract were investigated in C57BL/6 mice transplanted with Lewis lung cancer (LL-2) cells, and in BALB/c nude mice transplanted with A549 or SBC-3 human lung cancer cells. Oral administration of L. strychifolia extract prolonged survival time and inhibited tumor growth in a dose-dependent manner by inducing apoptosis in the LL-2 cell mice model. Furthermore, in A549 or SBC-3 cell nude mice models, oral administration of L. strychifolia extract also significantly inhibited tumor growth at the 5.0 mg/ml concentration. These findings suggested that the components of L. strychifolia have anticancer activity and may contribute to clinical applications in the prevention and treatment of lung cancer.


Subject(s)
Carcinoma, Lewis Lung/drug therapy , Drugs, Chinese Herbal/pharmacology , Lindera , Lung Neoplasms/drug therapy , Phytotherapy , 3T3-L1 Cells , Adenocarcinoma , Administration, Oral , Animals , Apoptosis/drug effects , Carcinoma, Lewis Lung/mortality , Carcinoma, Small Cell , Cell Line, Tumor/chemistry , Cell Line, Tumor/cytology , Cell Line, Tumor/drug effects , Cell Survival/drug effects , Humans , In Situ Nick-End Labeling , Lung Neoplasms/mortality , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Nude , Neoplasm Transplantation , Proliferating Cell Nuclear Antigen/analysis , Survival Rate
6.
Circ J ; 66(8): 763-8, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12197603

ABSTRACT

The present study used isolated rat hearts to investigate whether (1) Sheng-Mei-San (SMS), a traditional Chinese formulation comprising Radix Ginseng, Radix Ophiopogonis and Fructus Schisandrae, is protective against post-ischemic myocardial dysfunction, and (2) whether the cardioprotective effect of SMS is related to scavenging of hydroxyl radicals and opening the mitochondrial KATP channels. The excised hearts of male Sprague-Dawley rats were perfused on a Langendorff apparatus with Krebs-Henseleit solution with a gas mixture of 95% O2 and 5% CO2. Left ventricular end-diastolic pressure (LVEDP, mmHg), left ventricular developed pressure (LVDP, mmHg), +/-dP/dt (mmHg/s) and coronary flow (ml/min) were continuously monitored. All hearts were perfused for a total of 120 min consisting of a 30-min pre-ischemic period followed by a 30-min global ischemia and 60-min reperfusion. Lactate, lactate dehydrogenase (LDH) and 2,5-dihydroxybenzoic acid (2,5-DHBA) concentrations in the effluent were measured during reperfusion. Three days' treatment with SMS (1.67 ml/kg per day) inhibited the rise in LVEDP and improved the post-ischemic LVDP and +/-dP/dt significantly better than in the untreated control hearts during reperfusion. SMS increased the coronary flow at baseline, and during reperfusion. Pretreatment with 5-hydroxydecanoic acid (5-HD), a mitochondrial KATP channel blocker, abolished the inhibition of the rise in LVEDP, the increase in coronary flow and the improvement in LVDP and +/-dP/dt induced by SMS. SMS significantly attenuated the concentrations of lactate, LDH and 2,5-DHBA during reperfusion, but the pretreatment with 5-HD restored them; 5-HD alone did not affect the concentrations. SMS improved the post-ischemic myocardial dysfunction through opening the mitochondrial KATP channels.


Subject(s)
Adenosine Triphosphate/metabolism , Cardiomyopathies/prevention & control , Cardiotonic Agents/therapeutic use , Drugs, Chinese Herbal/therapeutic use , Gentisates , Mitochondria, Heart/metabolism , Myocardial Ischemia/drug therapy , Potassium Channels/metabolism , Animals , Drug Combinations , Hydroxybenzoates/metabolism , In Vitro Techniques , L-Lactate Dehydrogenase/metabolism , Lactic Acid/metabolism , Male , Myocardial Ischemia/physiopathology , Myocardium/metabolism , Potassium Channels/drug effects , Rats , Rats, Sprague-Dawley , Recovery of Function , Ventricular Function, Left
SELECTION OF CITATIONS
SEARCH DETAIL
...